AI assistant
DEXCOM INC — Director's Dealing 2017
Apr 24, 2017
30198_dirs_2017-04-24_bafd1f0c-6996-4b97-baa9-437ed16e3514.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2017-04-20
Reporting Person: GREGG TERRANCE H (Director, Executive Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-04-20 | Common Stock | S | 15000 | $74.1 | Disposed | 40882 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 454559 | Direct |
| Common Stock | 11461 | Indirect |
Footnotes
F1: The reporting person contributed Dexcom, Inc. Common Stock to an exchange fund, pursuant to an agreement dated March 13, 2017 to contribute shares of DexCom, Inc. Common Stock in exchange for shares of the exchange fund. The Dexcom, Inc. Common Stock was valued at $74.10 per share for the purposes of determining the number of shares of the exchange fund issuable to the reporting person with respect to the April 20, 2017 closing of the exchange fund.
F2: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.